CRYBG1 (crystallin beta-gamma domain containing 1)

2017-04-01  

Identity

HGNC
CRYBG1
LOCATION
6q21
LOCUSID
202
ALIAS
AIM1,ST4
FUSION GENES
Show Gene Fusions

Other Information

Locus ID:

NCBI: 202
MIM: 601797
HGNC: 356
Ensembl: ENSG00000112297

Variants:

dbSNP: 202
ClinVar: 202
TCGA: ENSG00000112297
COSMIC: CRYBG1

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000112297ENST00000369066Q9Y4K1
ENSG00000112297ENST00000457437Q96QW7
ENSG00000112297ENST00000633556A0A0J9YWL0
ENSG00000112297ENST00000651520A0A494C1M5

Protein levels (Protein atlas)

Not detected
Low
Medium
High
cerebral cortex
cerebellum
hippocampus
caudate
thyroid gland
parathyroid gland
adrenal gland
nasopharynx
bronchus
lung
oral mucosa
salivary gland
esophagus
stomach 1
stomach 2
duodenum
small intestine
colon
rectum
liver
gallbladder
pancreas
kidney
urinary bladder
testis
epididymis
seminal vesicle
prostate
vagina
ovary
fallopian tube
endometrium 1
endometrium 2
cervix, uterine
placenta
breast
heart muscle
smooth muscle
skeletal muscle
soft tissue 1
soft tissue 2
adipose tissue
skin 1
skin 2
appendix
spleen
lymph node
tonsil
bone marrow

References

Pubmed IDYearTitleCitations
273788182016Single-molecule Force Spectroscopy Reveals the Calcium Dependence of the Alternative Conformations in the Native State of a βγ-Crystallin Protein.5
273788182016Single-molecule Force Spectroscopy Reveals the Calcium Dependence of the Alternative Conformations in the Native State of a βγ-Crystallin Protein.5
240942922013DNMT1 and AIM1 Imprinting in human placenta revealed through a genome-wide screen for allele-specific DNA methylation.28
240942922013DNMT1 and AIM1 Imprinting in human placenta revealed through a genome-wide screen for allele-specific DNA methylation.28
221278952012AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomy.8
224024382012AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome.38
227619062012High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer.40
221278952012AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomy.8
224024382012AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome.38
227619062012High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer.40
199105432010Confirmation of genomewide association signals in Chinese Han population reveals risk loci for ischemic stroke.7
203796142010Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.78
199105432010Confirmation of genomewide association signals in Chinese Han population reveals risk loci for ischemic stroke.7
203796142010Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.78
191944642009Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies.78

Citation

Dessen P

CRYBG1 (crystallin beta-gamma domain containing 1)

Atlas Genet Cytogenet Oncol Haematol. 2017-04-01

Online version: http://atlasgeneticsoncology.org/gene/56781/crybg1-(crystallin-beta-gamma-domain-containing-1)